The Polyplastics Group has been serving the medical and healthcare industry for decades with its high purity Cyclic Olefin Copolymer, TOPAS^® COC. Now it is expanding its portfolio with newly developed Polyoxymethylene (POM) materials, the “DURACON^® POM PM Series”. These materials will be presented at leading exhibitions around the world:

MD&M West 2023 – Anaheim, California, U.S.A.
Date:  7-9 February 2023
Venue: Anaheim Convention Center
Booth No.: 1260
Official Website: https://www.mdmwest.com/en/home.html

Pharmapack Europe – Paris, France
Date: 1-2 February 2023
Venue: Paris Expo, Porte de Versailles
Booth No.: Hall 7.2, No. H40
(Represented by TOPAS Advanced Polymers GmbH)
Offical Website: https://www.pharmapackeurope.com/en/home.html

Our DURACON^® POM PM Series meets regulatory compliance requirements including ISO 10993 and USP Class VI biocompatibility / cytotoxicity, FDA Drug Master File (DMF) and Device Master File (MAF), and EU 10/2011 and FDA food contact 21 CFR 177.2470.

The materials adhere to strict quality management systems including conformity to VDI guideline and VDI 2017 medical-grade plastics. They also provide full traceability of processes and products, and production management based on GMP principles. Polyplastics provides uniform quality with global supply and service.

DURACON^® PM Series offers multiple viscosities to cover different customer requirements. DURACON^® PM09S01N grade with standard viscosity is suitable for medical equipment and components made by injection molding. On the other hand, the high-flow DURACON^® PM27S01N grade is suitable for thin-wall molding, enabling miniaturization and light-weighing.

Please also visit: https://www.polyplastics-global.com/en/approach/12.html